Published: February 17, 2010
Pathway Genomics Licenses Harvard Health Content for Personalized Genetic Test Reports
SAN DIEGO - (BUSINESS WIRE) - Pathway Genomics (www.PATHWAY.com),
a privately held, venture-backed company today announced an agreement
with StayWell Consumer Health Publishing to feature a robust suite of
consumer health information in Pathway's Genetic Health Reports. Content
developed by Harvard Medical School and Harvard Health Publications
provides Pathway customers with access to information about many aspects
of a medical condition including symptoms, diagnosis, expected duration,
prevention, and treatment options. This content represents the expertise
of 8,000 Harvard faculty physicians and world-renowned affiliated
hospitals.
"When customers review their Genetic Health Reports they want to easily
access detailed information-from a trusted source—about health
conditions reported with their genetic results," said Michael Nova,
M.D., Chief Medical Officer at Pathway Genomics. "By drawing on the
expertise of Harvard Medical School and Harvard Health Publications we
can help our customers quickly obtain this information and provide
answers to common questions."
The Pathway Genomics Genetic Health Report currently reports on more
than 70 health conditions, including an individual's propensity for
disease, carrier status, and drug response. For each complex disease
reported, customers can access additional information about the
condition. For example, information about diabetes informs customers
that there are three types of diabetes mellitus: type 1 diabetes, type 2
diabetes, and gestational diabetes. Symptoms of diabetes usually come on
suddenly and strong, diagnosis of this health condition is completed by
testing the blood for sugar levels, and prognosis for people with type 1
diabetes is that they generally adjust quickly to the time and attention
that is needed to monitor blood sugar, treat the disease, and maintain a
normal lifestyle.
"Genetic testing tells us with great accuracy if an individual has a
particular genetic marker, but it does not predict with absolute
certainty whether that person will or will not develop that disease,"
said Linda Wasserman, M.D., Ph.D., Director of Clinical Genetics and
head of Pathway's genetic counseling team. "This is where the role of
genetic counseling comes into play, and it is a critical factor in
helping customers understand their genetic results. By providing
additional content from experts at Harvard Medical School and Harvard
Health Publications on our web site, we can quickly refer our customers
to a source of information that is current and accurate."
About Pathway Genomics
Located in San Diego, California, Pathway Genomics is a privately held,
venture-backed company that offers both genetic health and ancestry
reports. Using customized and innovative DNA genetic testing
technologies, Pathway Genomics generates personalized reports about an
individual's carrier status, pharmacogenomics (drug response),
propensity for complex disease and ancestral history. Pathway Genomics
has both its federal CLIA and California state licenses for its wholly
owned and operated onsite laboratory. In this laboratory, Pathway
Genomics performs all genetic testing in a controlled and secure
environment. The Company offers personal genetic tests directly to the
consumer as well as through partnerships with select health management
organizations. More information about Pathway Genomics can be found at www.PATHWAY.com.
Pathway Genomics
Media
Maurissa Bornstein
Maurissa.Bornstein@pathway.com
858-997-0826
or
Partnerships
& Alliances
Jim Woodman
Jim.Woodman@pathway.com
858-771-0533
Copyright © 2012, Business Wire, Inc., All rights reserved.
Copyright © 2012, NewsBlaze,
Daily News
Search News
